跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
联系专家
查看 Scopus 资料
Top Karina Anne Marie
Professor
Dalhousie University
,
Decision Sciences
电子邮件
TK936353
dal
ca
网站
https://www.scopus.com/authid/detail.url?authorId=57211936353
h-index
h10-index
h5-index
1705
引用
22
H-指数
根据存储在 Pure 中的刊物数量以及来自 PlumX 的引用文献数量进行计算
1337
引用
20
H-指数
根据存储在 Pure 中的刊物数量以及来自 PlumX 的引用文献数量进行计算
554
引用
11
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2005
2023
每年的科研成果
综述
指纹
网络
科研成果
(81)
新闻 / 媒体
(97)
相似简介
(6)
指纹
深入其中 Top Karina Anne Marie 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Medicine and Dentistry
Adverse Event
91%
Infection
55%
Vaccine
49%
Pediatrics
49%
Influenza Vaccine
48%
Disease
40%
COVID-19
38%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Case Definition
35%
Public Health
32%
Odds Ratio
31%
Pertussis
28%
COVID-19 Vaccine
27%
Clinical Trial
26%
Diphtheria
24%
Tetanus
24%
Epileptic Seizure
23%
Recurrent Disease
23%
Cohort Analysis
22%
Revaccination
21%
Kawasaki Disease
21%
Influenza Vaccination
20%
Seasonal Influenza
17%
Contraindication
16%
Diphtheria Pertussis Tetanus Vaccine
13%
Health Care Provider
13%
Logistic Regression Analysis
13%
COVID-19 Vaccination
12%
Pediatrician
12%
Pertussis Vaccine
12%
Symptom
12%
Disease Severity
12%
Headache
11%
Rubella
11%
Mumps
11%
Measles
11%
Health Outcomes
10%
Virtual Patient
10%
Transplantation
10%
Serositis
10%
Poliomyelitis Vaccine
10%
Newborn Infection
10%
Influenza A
10%
Oncology
10%
Haemophilus Influenza Type B Infection
10%
Pediatric Hematology
10%
Gene Linkage
10%
Acute Lymphoblastic Leukemia
10%
Malignant Neoplasm
10%
University Student
10%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Vaccination Policy
72%
Vaccine
64%
Disease
52%
Infection
51%
Clinical Trial
33%
Influenza Vaccine
32%
Cohort Study
32%
COVID-19 Vaccine
27%
Seasonal Influenza
25%
Recurrent Disease
23%
Inflammation
23%
Inactivated Vaccine
21%
Mucocutaneous Lymph Node Syndrome
21%
Pertussis
19%
Immunogenicity
12%
Agrotis
12%
Diphtheria Pertussis Tetanus Vaccine
12%
Pharmacovigilance
12%
Disease Severity
12%
Headache
11%
Chickenpox Vaccine
11%
SARS Coronavirus
11%
Chickenpox
10%
Pericarditis
10%
Acute Lymphoblastic Leukemia
10%
Biological Product
10%
Retrospective Study
10%
Antiinfective Agent
10%
Myocarditis
10%
Influenza A
10%
Off-Label Use
10%
Syndrome
10%
Monoclonal Antibody
10%
Influenza B
10%
Paresthesia
10%
Interleukin 1 Receptor
10%
Pandemic
10%
mRNA Vaccine
9%
Symptom
9%
Pertussis Vaccine
7%
Antibiotic Prophylaxis
7%
Cefprozil
7%
Live Attenuated Influenza Vaccine
6%
Chemotherapy
6%
Rubella
6%
Tetanus
6%
Diphtheria
6%
Observational Study
6%
Injection Site Reaction
5%
Keyphrases
Immunization
57%
Monitoring Program
38%
Immunization Monitoring
38%
Hospitalization
31%
Adverse Events Following Immunization
27%
Confidence Interval
23%
Active Surveillance
22%
Pediatric Transplantation
21%
Network Studies
21%
Childhood Epilepsy
21%
Vaccine Program
21%
Kawasaki Disease
21%
Live Vaccine
18%
Canada
17%
Influenza
17%
Vaccination
16%
Immunization Surveillance
15%
Epilepsy
15%
Health Events
13%
Pediatric Hospitalization
13%
Immunization Programs
13%
Adjusted Odds Ratio
13%
Vaccinees
12%
Vaccination Program
12%
Haemophilus Influenzae Type b
12%
Pregnant Women
12%
Child Hospitalized
11%
Pediatric Hospital
11%
Stakeholder Approach
10%
Solid Organ Transplant
10%
Sars-cov-2 Infection
10%
Guillain-Barré Syndrome
10%
Anovaginal
10%
Vaccine Regulation
10%
Virtual Patient
10%
Pediatric Residents
10%
Emergency Department Visits
10%
Children with Cancer
10%
Immunization Practices
10%
Vaccine Use
10%
Climate Change
10%
University Setting
10%
Meta-analysis
10%
Systematic Meta-analysis
10%
Older children
10%
Antenatal Exposure
10%
Solid Organ Transplant Recipients
10%
Risk Interval
10%
Interval Analysis
10%
Multisystem Inflammatory Syndrome in Adults (MIS-A)
10%
